Chemed Corporation
CHE
$403.47
-$4.41-1.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.53B | 2.53B | 2.51B | 2.49B | 2.43B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.53B | 2.53B | 2.51B | 2.49B | 2.43B |
| Cost of Revenue | 1.71B | 1.70B | 1.67B | 1.62B | 1.58B |
| Gross Profit | 823.18M | 832.13M | 845.22M | 866.66M | 854.35M |
| SG&A Expenses | 414.49M | 415.94M | 412.14M | 414.07M | 419.02M |
| Depreciation & Amortization | 64.84M | 64.34M | 63.81M | 63.26M | 63.05M |
| Other Operating Expenses | 0.00 | -63.00K | -52.00K | -41.00K | 0.00 |
| Total Operating Expenses | 2.19B | 2.18B | 2.14B | 2.10B | 2.06B |
| Operating Income | 343.86M | 351.92M | 369.32M | 389.36M | 372.28M |
| Income Before Tax | 355.78M | 370.46M | 387.94M | 410.65M | 399.47M |
| Income Tax Expenses | 90.54M | 91.65M | 97.60M | 101.92M | 97.47M |
| Earnings from Continuing Operations | 265.24 | 278.81 | 290.35 | 308.74 | 302.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 265.24M | 278.81M | 290.35M | 308.74M | 302.00M |
| EBIT | 343.86M | 351.92M | 369.32M | 389.36M | 372.28M |
| EBITDA | 404.40M | 411.96M | 428.83M | 448.32M | 431.03M |
| EPS Basic | 18.45 | 19.05 | 19.63 | 20.73 | 20.12 |
| Normalized Basic EPS | 15.72 | 15.84 | 16.41 | 17.25 | 16.87 |
| EPS Diluted | 18.37 | 18.92 | 19.46 | 20.54 | 19.92 |
| Normalized Diluted EPS | 15.65 | 15.72 | 16.26 | 17.08 | 16.69 |
| Average Basic Shares Outstanding | 57.60M | 58.46M | 59.09M | 59.60M | 60.10M |
| Average Diluted Shares Outstanding | 57.89M | 58.87M | 59.63M | 60.18M | 60.75M |
| Dividend Per Share | 2.20 | 2.10 | 2.00 | 1.90 | 1.80 |
| Payout Ratio | 11.95% | 11.01% | 10.17% | 9.19% | 8.97% |